Chengda Pharmaceutical: Net profit in the first quarter of 2026 was 7.02 million yuan, turning losses into gains year-on-year.

Chengda Pharmaceutical Announcement: The revenue for the first quarter of 2026 was 128 million yuan, an increase of 68.06% year-on-year; net profit was 7.002 million yuan, compared to a loss of 1.4 million yuan in the same period last year.